US Representative
Nikki Budzinski Authored & Sponsored Legislation
Primary Sponsor of Legislation
US
Us Congress 2025-2026 Regular Session
Us Congress House Bill HB1051
Introduced
2/6/25
Refer
2/6/25
To amend the Federal Food, Drug, and Cosmetic Act to allow for the approval of an abbreviated new drug application submitted by a subsequent applicant in the case of a failure by a first applicant to commence commercial marketing within a certain period, and for other purposes.